Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model
- 27 December 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 318 (1) , 141-144
- https://doi.org/10.1016/s0014-2999(96)00857-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Differences between 5‐HT3 receptor antagonists in modulation of visceral hypersensitivityBritish Journal of Pharmacology, 1995
- Pharmacological Characterization of 5-Hydroxytryptamine3Receptors in Murine Brain and Ileum Using the Novel Radioligand [3H]RS-42358?197: Evidence for Receptor HeterogeneityJournal of Neurochemistry, 1993
- Effect of a 5HT3‐antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 1993
- Reduction of rectal sensitivity and post‐prandial motility by granisetron, a 5 HT3‐receptor antagonist, in patients with irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 1993
- Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple questionPain, 1991
- 5‐HT3 receptorsMedicinal Research Reviews, 1990
- The effects of granisetron, ICS 205–930 and ondansetron on the visceral pain reflex induced by duodenal distensionBritish Journal of Pharmacology, 1990
- 5-Hydroxytryptamine: New Receptors and Novel Drugs for Gastrointestinal Motor DisordersScandinavian Journal of Gastroenterology, 1990
- Influence of a specific 5-HT3 antagonist on carrageenan-induced hyperalgesia in ratsPain, 1989
- Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the ratBrain Research, 1988